Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2113 of 6351
-
Drug combo shows promise for tough blood cancer
Disease control OngoingThis phase I trial studies the side effects and best dose of ibrutinib and palbociclib in treating patients with previously treated mantle cell lymphoma. Ibrutinib and palbociclib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Palbocic…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a diabetes drug boost lung cancer treatment?
Disease control CompletedThis randomized phase II trial studies how well chemotherapy and radiation therapy given with or without metformin hydrochloride works in treating patients with stage III non-small cell lung cancer. Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different…
Phase 2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New chemo drug shows promise for tough testicular cancers
Disease control CompletedCabazitaxel is a new generation taxane with a high capacity for blood-brain barrier crossing and limited peripheral neuro-toxicity, two major potential advantages in patients with advanced NSGCTs. Cabazitaxel has a broader in vitro spectrum of activity than docetaxel. Taxanes ha…
Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could fewer injections protect bones just as well? major trial tests every-12-week denosumab
Disease control OngoingThe aim of the trial is to test the hypothesis that the benefit of denosumab is maintained if administered only every 12 weeks as compared to every 4 weeks.
Phase 3 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug combo shrinks spleens in bone marrow cancer patients
Disease control CompletedPhase 1 Part: This was an open-label, sequential dose escalation study of pelabresib (CPI-0610) in patients who had previously been treated for Acute Leukemia, Myelodysplastic/Myeloproliferative Neoplasms. Phase 2 Part: This was an open-label study of pelabresib (CPI-0610), admi…
Phase 1/2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could cannabis narrow brain arteries and raise stroke risk?
Knowledge-focused Stopped earlyThere is an association between intracranial arterial stenosis and ischemic stroke in young adults. The aim of this study is to evaluate the prevalence of intracranial arterial stenosis in asymptomatic regular resin of cannabis users in comparison with control subjects.
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
New combo therapy aims to tackle tough pancreatic tumors
Disease control OngoingThe investigators hypothesize that intensification of local therapy will lead to improvements in local control and survival in patients with unresectable and borderline resectable pancreatic cancer. We propose to do this by combining nab-paclitaxel concurrently with dose-escalate…
Phase 1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Ice treatment for kidney cancer shows promise in latest trial
Disease control OngoingThis experiment is designed for post marketing data collection of a cryosurgical system \[PROSENSE™ of IceCure Medical\], for the treatment of renal cell carcinoma (RCC).
Sponsor: IceCure Medical Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Pancreatic cancer radiation gets a boost: safety trial tests higher doses
Disease control CompletedThis study is to determine the maximum tolerated dose (MTD) of five fraction stereotactic radiotherapy (SBRT) in pancreatic cancer.
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 26, 2026 15:26 UTC
-
New drug cocktail shows promise for Hard-to-Treat myeloma
Disease control CompletedThis phase I trial studies the side effects and best dose of selinexor and carfilzomib when given together with dexamethasone in treating patients with multiple myeloma that has returned or does not respond to treatment. Drugs used in chemotherapy, such as selinexor and dexametha…
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can a Dual-Chamber device shrink an enlarged heart in AF patients?
Disease control CompletedAtrial fibrillation (AF) and heart failure (HF) are two common heart conditions that are encountered with an increase in death and suffering. When both these two conditions occur in a patient, the patient's prognosis is poor with a reduced quality of life and impaired heart funct…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Can a 'Love Hormone' spray tame Prader-Willi symptoms?
Symptom relief CompletedThe investigator thinks that the oxytocin (OT) can improve durably and significantly the behavior disorders and thus the socialization but also the satisfaction and could thus be an interesting therapeutic alternative for the patients presenting a Prader-Willi Syndrome (SPW). Alt…
Phase 2/3 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Gene test guides treatment for rare salivary gland tumors
Disease control CompletedThis is a study of select drug therapies in patients with salivary gland cancer. The study has two phases: a molecular profiling phase (phase 1) and a treatment phase (phase 2). Based on the Molecular profiling results in phase the participants will receive matched treatment if …
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Radioactive injection shrinks brain cysts without surgery
Disease control Recruiting nowThere is no consensus in the literature on the best way to treat cystic lesions of the pituitary area. Patients who are symptomatic from these tumours are rare. The cystic form of tumours present special challenges since traditional treatment modalities (surgery and/or external r…
Phase 3 • Sponsor: David Clarke • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Custom brace and therapy aim to get wounded warriors back on their feet
Disease control CompletedThe goal of the PRIORITI-MTF study is to help determine whether a new type of custom designed brace, called the IDEO ™ along with a physical therapy program, called Return to Run, improves physical function. This brace was developed for wounded warriors who wanted to return to an…
Sponsor: Major Extremity Trauma Research Consortium • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Proton beam therapy aims to spare kids with neuroblastoma from harsh side effects
Disease control OngoingThis research study is evaluating a therapy called proton beam radiation therapy (PBRT) as a possible treatment for neuroblastoma. Neuroblastoma most commonly occurs in and around the adrenal glands, which are located at the top of the kidneys. However, it can also occur in othe…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Experimental drug duo targets Hard-to-Treat cancers
Disease control OngoingThis phase I trial studies the side effects and best dose of raptor/rictor-mammalian target of rapamycin (mTOR) (TORC1/2) inhibitor MLN0128 when given in combination with bevacizumab in treating patients with glioblastoma, a type of brain tumor, or a solid tumor that has spread a…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug cocktail shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis phase I trial studies the side effects and best dose of lenalidomide when given together with ibrutinib and rituximab in treating patients with chronic lymphocytic leukemia or small lymphocytic lymphoma that has come back (relapsed), has not responded well to prior treatment…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Heated chemo during surgery may fight ovarian cancer return
Disease control OngoingThis phase I trial studies the side effects and how well surgery and heated chemotherapy with or without non-heated chemotherapy after surgery works in treating patients with ovarian, fallopian tube, uterine, or peritoneal cancer. Giving a dose of heated chemotherapy into the abd…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Which shock drug is safest? large ICU trial aims to find out
Disease control Recruiting nowThe investigators hypothesis is that for ICU patients with shock, the use of the vasoactive drugs phenylephrine and vasopressin will reduce tachydysrhythmias when compared to norepinephrine and epinephrine. To investigate this hypothesis, the investigators are conducting a random…
Phase 4 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC